On Wednesday, Canada became the first country in the world to authorize the use of the Pfizer vaccine against COVID-19 in the 12 to 15-year-old population. The decision came after local authorities approved its administration to minors.
Health Canada’s chief medical advisor, Supriya Sharma, said there is evidence that the vaccine is safe and effective in that age group. “This is the first vaccine licensed in Canada for the prevention of Covid-19 in children and is a significant milestone in Canada’s fight against the pandemic,” Sharma told a news conference.
Use of the Pfizer vaccine after trials
Similarly, Sharma said that although COVID-19 is less likely to cause severe symptoms in children, vaccinating this population group will help control the spread of the disease to their families and friends.
"*" indicates required fields
The approval came after Pfizer tested the vaccine in more than 2,200 children between 12 and 15 years of age and determined that the drug is safe and protects this group against the disease.